Author:
Tasaki Masayoshi,Lavatelli Francesca,Obici Laura,Obayashi Konen,Miyamoto Takeshi,Merlini Giampaolo,Palladini Giovanni,Ando Yukio,Ueda Mitsuharu
Funder
Takeda Science Foundation
Japan Society for the Promotion of Science
Subject
Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology
Reference119 articles.
1. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;N. Engl. J. Med.,2018
2. Guideline of transthyretin-related hereditary amyloidosis for clinicians;Ando;Orphanet J. Rare Dis.,2013
3. Quadriceps tendon rupture in wild-type transthyretin amyloidosis (ATTRwt);Barge-Caballero;Eur. Heart J.,2019
4. Amyloid Damage to Islet β-cells in Type 2 Diabetes: Hypoxia or Pseudo-hypoxia?;Bellotti,2019
5. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy;Benson;Amyloid,2017
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献